Most medical device companies are not short on inventory.
They are short on the right inventory, in the right place, at the right time.
Inventory sits in one part of the network while demand materializes somewhere else. Critical products are unavailable where procedures are happening, while excess builds up in manufacturing sites or distribution centers. From a distance, the numbers may look right. In practice, the network is out of balance.
The issue is not how much inventory exists.
It is how that inventory is positioned.
Medical device supply chains are inherently complex, but not just because of scale. The challenge comes from how demand actually behaves.
Unlike many industries, demand is closely tied to procedures, patient volumes, and physician preference. It shifts by region, by facility, and often with very little notice. At the same time, product portfolios are constantly evolving, with new introductions, updates, and phase outs happening in parallel.
Now layer in how inventory is distributed.
Products are not held in a single location. They are spread across manufacturing sites, distribution centers, field locations, and often inside hospitals themselves through consignment models. On paper, inventory exists. In reality, it is not always where it needs to be.
That gap between availability and accessibility is where the problem lives.
When inventory is in the wrong place, the organization compensates.
Teams expedite shipments to meet urgent needs. Inventory is transferred between locations. Planners and operations teams step in to manually resolve shortages. Over time, these actions become normalized. They are seen as part of the job rather than symptoms of a deeper issue.
At the same time, inventory levels quietly increase. More stock is added as a buffer against uncertainty, but without addressing the root cause. The result is a network that carries more inventory than necessary, yet still struggles to meet demand reliably.
In a medical device environment, the stakes are higher. Product availability is not just a service metric. It directly impacts procedures, outcomes, and patient care.
Many planning processes were built for more stable environments. They rely on aggregated forecasts, static targets, and periodic updates. That approach assumes demand patterns are relatively predictable and that inventory can be managed in broad strokes.
That assumption does not hold in medical device supply chains.
Demand shifts quickly and often at a local level. The tradeoffs between service and inventory are not static, and decisions made in one part of the network ripple across others. By the time traditional planning cycles catch up, the situation has already changed.
This is why so many organizations find themselves reacting. The plan may have been right at one point in time, but it no longer reflects reality.
The companies making progress are not simply trying to improve forecasts or increase inventory. They are changing the question.
Instead of asking, “Do we have enough inventory?”
They are asking, “Is our inventory positioned where it needs to be?”
That shift changes everything.
Inventory becomes something that is actively positioned across the network, not just accumulated. Decisions are made with location in mind, balancing service requirements, cost, and risk. As demand shifts, inventory is adjusted accordingly, rather than waiting for issues to surface.
This is not about perfection. It is about improving alignment between where demand occurs and where supply is available.
When inventory is positioned more effectively, the impact is noticeable across the organization.
The need for expedites and last minute transfers begins to decline. Inventory levels stabilize because they are no longer being used as a blanket buffer. Planning and operations teams spend less time reacting and more time making informed decisions.
Most importantly, product availability improves where it matters most. Not just somewhere in the network, but at the point of care.
For many medical device companies, the challenge is not recognizing these issues. They experience them every day.
The challenge is breaking the cycle.
When teams are constantly responding to shortages and shifting inventory, there is little room to step back and rethink how the system should work. But the organizations that do make that shift move from reactive firefighting to intentional planning.
They begin to anticipate where inventory needs to be before demand occurs, rather than chasing it after the fact.
Inventory strategy in medical devices is not about how much you carry.
It is about where it sits.
And for organizations willing to rethink how inventory is planned and positioned across their network, that shift can unlock meaningful improvements in service, cost, and overall performance.
